Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β₂-agonist in for patients with asthma

References

• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention updated 2015. Available from: http://www.ginathma.org [last accessed 10 July 2015].
   Google Scholar
• Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008;31:320–325.
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13.
   PubMedGoogle Scholar
• Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40–47.
   PubMed Web of Science ®Google Scholar
• Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003;327:891.
   PubMed Web of Science ®Google Scholar
• Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008;63:453–462.
   PubMed Web of Science ®Google Scholar
• Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211–216.
   PubMed Web of Science ®Google Scholar
• Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:578–585.
   PubMed Web of Science ®Google Scholar
• Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA et al., National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Eng J Med 2010;363:1715–1726.
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Disse B, Schröder-Babo W, Bantje TA, Gahlemann M, Sigmund R, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011;128:308–314.
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198–1207.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC et al. An official ATS clinical practice guideline. Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–615.
   PubMed Web of Science ®Google Scholar
• Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, Nishimura K et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 2000;162:1518–1523.
   PubMed Web of Science ®Google Scholar
• The Committee of Pulmonary Physiology, Japanese Respiratory Society. Guidelines for pulmonary function tests. Spirometry, flow volume curve, diffusion capacity of the lung. Tokyo. The Japanese Respiratory Society 2004 (in Japanese).
   Google Scholar
• Hoshino M, Matsuoka S, Handa H, Miyazawa T, Yagihashi K. Correlation between airflow limitation and airway dimensions assessed by multidetector CT in asthma. Respir Med 2010;104:794–800.
   PubMed Web of Science ®Google Scholar
• Hoshino M, Ohtawa J. Effects of budesonide/formoterol combination versus budesonide on airway dimensions in asthma. Respirology 2012;17:639–646.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102–1108.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76–83.
   PubMed Web of Science ®Google Scholar
• Ichinose M, Takahashi T, Sugiura H, Endoh N, Miura M, Mashito Y, Shirato K et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J 2000;15:248–253.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111:S18–S34.
   PubMedGoogle Scholar
• Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197–206.
   PubMed Web of Science ®Google Scholar
• Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF, Juniper EF et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011;364:1695–1707.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999;14:12–18.
   PubMed Web of Science ®Google Scholar
• Ramsay CF, Sullivan P, Gizycki M, Wang D, Swern AS, Barnes NC, Reiss TF et al. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Respir Med 2009;103:995–1003.
   PubMed Web of Science ®Google Scholar
• Volovitz B, Tabachnik E, Nussinovitch M, Shtaif B, Blau H, Gil-Ad I, Weizman A et al. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 1999;104:1162–1167.
   PubMed Web of Science ®Google Scholar
• van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;64:2107–2113.
   Google Scholar
• Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693–1722.
   PubMed Web of Science ®Google Scholar
• Stirling RG, Kharitonov SA, Campbell D, Robinson DS, Durham SR, Chung KF, Barnes PJ. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Thorax 1998;53:1030–1034.
   PubMed Web of Science ®Google Scholar
• Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;49:953–959
   Google Scholar
• O'Shaughnessy KM, Wellings R, Gillies B, Fuller RW. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis 1993;147:1472–1476.
   PubMed Web of Science ®Google Scholar
• Dupont L, Potvin E, Korn D, Lachman A, Dramaix M, Gusman J, Peché R et al. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. Curr Med Res Opin 2005;21:863–869.
   PubMed Web of Science ®Google Scholar
• Korn D, Van den Brande P, Potvin E, Dramaix M, Herbots E, Peché R. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin 2009;25:489–497.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Mehta A, Ljungblad L, Mitfessel H. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. J Asthma 2010;47:986–993.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Mehta A, Ljungblad L, Mitfessel H, MONICA study group. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Respir Med 2010;104:644–651.
   PubMed Web of Science ®Google Scholar
• Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003;167:1232–1238.
   PubMed Web of Science ®Google Scholar
• Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H, Zaagsma J. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007;30:653–661.
   PubMed Web of Science ®Google Scholar
• Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005;171:1096–1102.
   PubMed Web of Science ®Google Scholar
• Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108–116.
   PubMed Web of Science ®Google Scholar
• Ohta S, Oda N, Yokoe T, Tanaka A, Yamamoto Y, Watanabe Y, Minoguchi K et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 2010;40:1266–1275.
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Bos ST, Mudde WM, Hylkema MN, Hiemstra PS, Wess J, Meurs H et al. Muscarinic M3 receptors contribute to allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 2014;50:690–698.
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Hiemstra PS, Bos IS, Bouwman S, van den Berge M, Hylkema MN, Meurs H et al. Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells. Thorax 2015;7:668–676.
   Google Scholar
• Gosens R, Dueck G, Rector E, Nunes RO, Gerthoffer WT, Unruh H, Zaagsma J et al. Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. Am J Physiol Lung Cell Mol Physiol 2007;293:L1348–1358.
   PubMed Web of Science ®Google Scholar
• Haag S, Matthiesen S, Juergens UR, Racké K. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 2008;32:555–562.
   PubMed Web of Science ®Google Scholar
• Oenema TA, Mensink G, Smedinga L, Halayko AJ, Zaagsma J, Meurs H, Gosens R et al. Cross-talk between transforming growth factor-β1 and muscarinic M2 receptors augments airway smooth muscle proliferation. Am J Respir Cell Mol Biol 2013;49:18–27.
   PubMed Web of Science ®Google Scholar
• Pahl A, Bauhofer A, Petzold U, Cnota PJ, Maus J, Brune K, Szelenyi S. Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs. Biochem Pharmacol 2006;72:1690–1696.
   PubMed Web of Science ®Google Scholar
• Grainge CL, Lau LC, Ward JA, Dulay V, Lahiff G, Wilson S, Holgate S, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011;364:2006–2015.
   PubMed Web of Science ®Google Scholar
• Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201–S205.
   PubMed Web of Science ®Google Scholar
• van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003;58:1268–1276.
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392–1397
   PubMed Web of Science ®Google Scholar
• King GG, Carroll JD, Müller NL, Whittall KP, Gao M, Nakano Y, Paré PD. Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT. Eur Respir J 2004;24:211–218.
   PubMed Web of Science ®Google Scholar
• Aysola RS, Hoffman EA, Gierada D, Wenzel S, Cook-Granroth J, Tarsi J, Zheng J et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest 2008;134:1183–1191.
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Gupta S, Cruse G, Haldar P, Entwisle J, Mcdonald S, Whithers PJ et al. Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis. Allergy 2009;64:951–958.
   PubMed Web of Science ®Google Scholar